Early research (Phase 1)Study completedNCT04770935
What this trial is testing
To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)
Who this might be right for
Von Willebrand's Disease (VWD)
Bioverativ, a Sanofi company 6